1. Anti-dengue infectivity evaluation of bioflavonoid from
- Author
-
Vivek Dhar, Dwivedi, Shiv, Bharadwaj, Sumbul, Afroz, Nooruddin, Khan, Mairaj Ahmed, Ansari, Umesh, Yadava, Ramesh Chandra, Tripathi, Indra Prasad, Tripathi, Sarad Kumar, Mishra, and Sang Gu, Kang
- Subjects
Dengue ,Flavonoids ,Molecular Docking Simulation ,Azadirachta ,Protease Inhibitors ,Dengue Virus ,Serine Proteases ,Viral Nonstructural Proteins ,Antiviral Agents - Abstract
Dengue virus (DENV) serine protease enzyme, i.e. NS2B-NS3pro (non-structural protein 2B-non-structural protein 3) has been approved as prime drug target for the drug discovery against dengue infection, because of its essential role in viral replication. This study demonstrates the potential of bioflavonoids from
- Published
- 2020